Suraksha Agrawal - Genetic Mutations

Author Information

Suraksha Agrawal is affiliated with the Department of Medical Genetics at Sanjay Gandhi Postgraduate Institute of Medical Sciences in Lucknow, India, and Srimann Super Specialty Hospital in Jalandhar, India. Her research primarily focuses on medical genetics and related fields, demonstrating a broad spectrum of interests within these disciplines.

Research Contributions

Suraksha Agrawal has made significant contributions to the field of genetics, with a particular focus on polymorphisms, autoimmune disorders, and the implications of genetic factors in various diseases. Her work has explored the role of KIR-like natural killer cell receptors in autoimmune disorders, the genetic underpinnings of coronary artery disease, and the diagnostic utility of biomarkers like procalcitonin in sepsis. Additionally, she has investigated the genetic aspects of diseases such as Autosomal Dominant Polycystic Kidney Disease and gall bladder cancer, providing valuable insights into disease progression and patient outcomes.

Aliases

Suraksha Agrawal is also known by several aliases, including S Agrawal, S. Agrawal, and S. B. Agrawal.

Publication and Citation Metrics

Metric	Value
Total Citations	3673
h-index	31
Total Papers	212

Publications:

Significance of KIR like natural killer cell receptors in autoimmune disorders.

DOI: 10.1016/j.clim.2020.108449

Year: 2020

PB2121 POST-TREATMENT IMMUNE RECONSTITUTION IN MYELOMA IS ASSOCIATED WITH IMPROVED PROGRESSION FREE SURVIVAL IN THE ERA OF NOVEL THERAPY; A RETROSPECTIVE ANALYSIS IN AN AUSTRALIAN HAEMATOLOGY DEPARTMENT

DOI: 10.1097/01.HS9.0000566968.54896.79

Year: 2019

Autosomal Dominant Polycystic Kidney Disease and Genetic Counseling

DOI:

Year: 2019

Procalcitonin as a diagnostic biomarker of sepsis: A tertiary care centre experience.

DOI: 10.1016/j.jiph.2018.11.004

Year: 2019

Unit-3 Genetic Polymorphism

DOI:

Year: 2018

Loughborough University Institutional Repository Paraoxonase 1 GENE polymorphisms contribute to coronary artery disease risk

DOI:

Year: 2018

Angiogenic factors polymorphisms in gall bladder cancer (GBC) progression and survival

DOI: 10.1016/j.hpb.2018.06.1412

Year: 2018

Vascular Endothelial Growth Factor Gene Polymorphism Is Associated With Long-term Kidney Allograft Outcomes

DOI: 10.1016/j.ekir.2017.10.008

Year: 2018

Different Expression Of MUC 1 In The Gallbladder Disease

DOI:

Year: 2018

Folate deficiency in north Indian children undergoing maintenance chemotherapy for acute lymphoblastic leukemia—Implications and outcome

DOI: 10.1002/pbc.26730

Year: 2018

What are the Challenges in Data Analysis?

What Are the Treatment Options?

What are the Current Therapeutic Innovations?

Where Do Neutral Mutations Typically Occur?

Are All Environmental Mutations Harmful?

What are the Options for Individuals with BRCA1 or BRCA2 Mutations?

How Does Third Generation Sequencing Work?

What is Hemoglobin Electrophoresis?

How are Patients Monitored During TKI Therapy?

Can Genetic Susceptibility Influence Mutation Risk?

Partnered Content Networks

Relevant Topics